EBO Profitability Analysis: Past Growth, Margins, Return on Capital, Free Cash Flow, and more - EBOS Group Ltd - Alpha Spread
E

EBOS Group Ltd
ASX:EBO

Watchlist Manager
EBOS Group Ltd
ASX:EBO
Watchlist
Price: 34.34 AUD 1.6% Market Closed
Market Cap: 6.6B AUD
Have any thoughts about
EBOS Group Ltd?
Write Note

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
EBOS Group Ltd

Revenue
13.2B AUD
Cost of Revenue
-11.6B AUD
Gross Profit
1.6B AUD
Operating Expenses
-1.2B AUD
Operating Income
482.5m AUD
Other Expenses
-211m AUD
Net Income
271.5m AUD

Margins Comparison
EBOS Group Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
NZ
EBOS Group Ltd
ASX:EBO
6.6B AUD
12%
4%
2%
US
Mckesson Corp
NYSE:MCK
66.2B USD
4%
1%
1%
US
Amerisourcebergen Corp
LSE:0HF3
45.3B USD
3%
1%
1%
US
Cencora Inc
NYSE:COR
44.4B USD
3%
1%
1%
US
Cardinal Health Inc
NYSE:CAH
27.1B USD
3%
1%
0%
US
Henry Schein Inc
NASDAQ:HSIC
9.2B USD
32%
5%
3%
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
30%
9%
7%
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
54.3B CNY
11%
3%
2%
CN
Sinopharm Group Co Ltd
HKEX:1099
53.4B HKD
8%
4%
1%
CN
Huadong Medicine Co Ltd
SZSE:000963
48.3B CNY
32%
9%
8%
IT
Amplifon SpA
MIL:AMP
6.1B EUR
25%
13%
7%
Country NZ
Market Cap 6.6B AUD
Gross Margin
12%
Operating Margin
4%
Net Margin
2%
Country US
Market Cap 66.2B USD
Gross Margin
4%
Operating Margin
1%
Net Margin
1%
Country US
Market Cap 45.3B USD
Gross Margin
3%
Operating Margin
1%
Net Margin
1%
Country US
Market Cap 44.4B USD
Gross Margin
3%
Operating Margin
1%
Net Margin
1%
Country US
Market Cap 27.1B USD
Gross Margin
3%
Operating Margin
1%
Net Margin
0%
Country US
Market Cap 9.2B USD
Gross Margin
32%
Operating Margin
5%
Net Margin
3%
Country KR
Market Cap 12.2T KRW
Gross Margin
30%
Operating Margin
9%
Net Margin
7%
Country CN
Market Cap 54.3B CNY
Gross Margin
11%
Operating Margin
3%
Net Margin
2%
Country CN
Market Cap 53.4B HKD
Gross Margin
8%
Operating Margin
4%
Net Margin
1%
Country CN
Market Cap 48.3B CNY
Gross Margin
32%
Operating Margin
9%
Net Margin
8%
Country IT
Market Cap 6.1B EUR
Gross Margin
25%
Operating Margin
13%
Net Margin
7%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
EBOS Group Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
NZ
EBOS Group Ltd
ASX:EBO
6.6B AUD
11%
4%
13%
8%
US
Mckesson Corp
NYSE:MCK
66.2B USD
-176%
4%
26%
19%
US
Amerisourcebergen Corp
LSE:0HF3
45.3B USD
230%
3%
21%
16%
US
Cencora Inc
NYSE:COR
44.4B USD
230%
3%
21%
16%
US
Cardinal Health Inc
NYSE:CAH
27.1B USD
-28%
2%
22%
17%
US
Henry Schein Inc
NASDAQ:HSIC
9.2B USD
10%
4%
9%
6%
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
7%
3%
9%
5%
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
54.3B CNY
6%
2%
10%
5%
CN
Sinopharm Group Co Ltd
HKEX:1099
53.4B HKD
12%
2%
16%
8%
CN
Huadong Medicine Co Ltd
SZSE:000963
48.3B CNY
15%
9%
17%
13%
IT
Amplifon SpA
MIL:AMP
6.1B EUR
15%
4%
12%
7%
Country NZ
Market Cap 6.6B AUD
ROE
11%
ROA
4%
ROCE
13%
ROIC
8%
Country US
Market Cap 66.2B USD
ROE
-176%
ROA
4%
ROCE
26%
ROIC
19%
Country US
Market Cap 45.3B USD
ROE
230%
ROA
3%
ROCE
21%
ROIC
16%
Country US
Market Cap 44.4B USD
ROE
230%
ROA
3%
ROCE
21%
ROIC
16%
Country US
Market Cap 27.1B USD
ROE
-28%
ROA
2%
ROCE
22%
ROIC
17%
Country US
Market Cap 9.2B USD
ROE
10%
ROA
4%
ROCE
9%
ROIC
6%
Country KR
Market Cap 12.2T KRW
ROE
7%
ROA
3%
ROCE
9%
ROIC
5%
Country CN
Market Cap 54.3B CNY
ROE
6%
ROA
2%
ROCE
10%
ROIC
5%
Country CN
Market Cap 53.4B HKD
ROE
12%
ROA
2%
ROCE
16%
ROIC
8%
Country CN
Market Cap 48.3B CNY
ROE
15%
ROA
9%
ROCE
17%
ROIC
13%
Country IT
Market Cap 6.1B EUR
ROE
15%
ROA
4%
ROCE
12%
ROIC
7%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More
Back to Top